聯合國大流行病條約談判因政策分歧而陷入僵局
UN Pandemic Treaty Negotiations Stall Over Policy Disputes
Updated at: September 30, 2026 at 01:50 AM
截至2026年9月,聯合國大流行病條約仍處於外交僵局。儘管該條約在2025年5月原則上獲得採納,但由於存在重大的政策分歧,該條約尚未作為國際法生效。主要的障礙在於病原體獲取與惠益分享(PABS)系統。該系統旨在平衡快速共享新病原體的基因序列與公平分配疫苗及治療方法。然而,談判在如何將此系統與智慧財產權及技術轉移相協調的問題上陷入了膠著。低收入國家主張對醫療對策擁有強制性的獲取權,而許多已開發國家則強調應透過自願機制來保護產業利益。更使問題複雜化的是,美國在2026年初退出世衛組織,以及關於國家主權和疫苗責任的持續辯論。根據第31條規定,在PABS附件完全達成共識之前,該條約無法定案。隨著期限延至2027年5月,國際社會面臨艱鉅的任務,即如何在國家利益與全球衛生安全之迫切需求之間取得協調,以防止新冠肺炎疫情期間經歷過的不平等現象再次發生。
As of September 2026, the UN Pandemic Treaty, also known as the WHO Pandemic Agreement, remains in diplomatic limbo. Although adopted in principle in May 2025, the treaty has yet to take effect as international law due to significant policy disagreements. The primary hurdle is the Pathogen Access and Benefit Sharing (PABS) system. This system is designed to balance the rapid sharing of genetic sequences from new pathogens with the equitable distribution of vaccines and treatments. However, negotiations are stuck on how to harmonize this with intellectual property rights and technology transfer. Lower-income countries advocate for enforceable access to medical countermeasures, while many developed nations emphasize voluntary mechanisms to protect industry interests. Further complicating matters is the withdrawal of the United States from the WHO in early 2026, alongside ongoing debates about national sovereignty and vaccine liability. Under Article 31, the treaty cannot be finalized until the PABS annex is fully agreed upon. With the deadline extended to May 2027, the international community faces the difficult task of reconciling national interests with the urgent need for global health security to prevent the inequities experienced during the COVID-19 pandemic.
